Literature DB >> 32247620

Androgen/androgen receptor affects gentamicin-induced nephrotoxicity through regulation of megalin expression.

Elsayed G E Elsakka1, Ahmad Mohamed Elsisi2, Osama Abd Al-Motaal Mansour3, Bakheet E M Elsadek4, Adel I Abd Elaziz5, Salama Abdou Salama6, Shady Allam7.   

Abstract

AIM: Investigation whether androgen/androgen receptor (AR) might regulate megalin expression and/or functionality and thus affecting Gentamicin-induced nephrotoxicity (GIN). MAIN
METHODS: Male Wistar rats were treated with gentamicin with/out AR ligands (testosterone as agonist and flutamide as antagonist). Megalin expression in the kidney tissues was determined by real-time RT-PCR and western blot. Besides, megalin functionality was assessed using immunofluorescence imaging of fluorescein isothiocyanate (FITC) conjugated bovine serum albumin (BSA) (FITC-BSA). The effects of different treatments on the kidney were assessed at the structural level by histopathological evaluation and the biochemical level by colorimetric assay of blood urea nitrogen (BUN), serum creatinine (SCr) and urinary albumin/creatinine (A/C) ratio, besides, kidney expression of neutrophil gelatinase-associated lipocalin (NGAL) by immunoblotting. KEY
FINDINGS: Our results revealed that treatment with testosterone either alone or combined with gentamicin increased megalin expression at mRNA and protein levels as well as at the functional level. These effects were paralleled by increased GIN as manifested by increased SCr, BUN, A/C ratio, renal expression of NGAL or histopathological changes. On the other hand, treatment with flutamide ameliorated GIN and megalin expression and functionality. Computational analysis of megalin promotor revealed the presence of multiple response elements that mediate androgen response. SIGNIFICANCE: Androgen/AR regulates megalin expression at the transcriptional level and consequently GIN. This may explain the sexual dimorphism in GIN and might represent a druggable target for treatment or prevention of GIN.
Copyright © 2020. Published by Elsevier Inc.

Entities:  

Keywords:  Androgen receptor; Flutamide; Gentamicin; Megalin; Nephrotoxicity; Testosterone

Year:  2020        PMID: 32247620     DOI: 10.1016/j.lfs.2020.117628

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  1 in total

1.  Effects of Androgen Receptor Inhibition on Kanamycin-Induced Hearing Loss in Rats.

Authors:  Kyung-Ju Chun; Chang-Ho Lee; Kyung-Woon Kim; So-Min Lee; So-Young Kim
Journal:  Int J Mol Sci       Date:  2021-05-18       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.